Biomarker screening using integrated bioinformatics for the development of "normal—impaired glucose intolerance—type 2 diabetes mellitus"

Dongqiang Luo,Xiaolu Gao,Xianqiong Zhu,Jiongbo Xu,Pengfei Gao,Jiayi Zou,Qiaoming Fan,Ying Xu,Tian Liu

DOI: https://doi.org/10.1038/s41598-024-55199-y

IF: 4.6

2024-02-25

Scientific Reports

Abstract:Type 2 diabetes mellitus (T2DM) is a progressive disease. We utilized bioinformatics analysis and experimental research to identify biomarkers indicative of the progression of T2DM, aiming for early detection of the disease and timely clinical intervention. Integrating Mfuzz analysis with differential expression analysis, we identified 76 genes associated with the progression of T2DM, which were primarily enriched in signaling pathways such as apoptosis, p53 signaling, and necroptosis. Subsequently, using various analytical methods, including machine learning, we further narrowed down the hub genes to STK17A and CCT5. Based on the hub genes, we calculated the risk score for samples and interestingly found that the score correlated with multiple programmed cell death (PCD) pathways. Animal experiments revealed that the diabetes model exhibited higher levels of MDA and LDH, with lower expression of SOD, accompanied by islet cell apoptosis. In conclusion, our study suggests that during the progression of diabetes, STK17A and CCT5 may contribute to the advancement of the disease by regulating oxidative stress, programmed cell death pathways, and critical signaling pathways such as p53 and MAPK, thereby promoting the death of islet cells. This provides substantial evidence in support of further disease prevention and treatment strategies.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper aims to identify biomarkers associated with the progression of Type 2 Diabetes Mellitus (T2DM) through bioinformatics analysis and experimental research, in order to achieve early detection and timely clinical intervention of the disease. Specifically, the paper integrates Mfuzz analysis and differential expression analysis to identify 76 genes related to T2DM progression. KEGG pathway enrichment analysis shows that these key genes are significantly enriched in various pathways, particularly apoptosis, p53 signaling pathway, MAPK signaling pathway, and necroptosis.

Through a series of analytical methods, including protein-protein interaction (PPI) network, MCODE, and SVM analysis, researchers identified two core hub genes: STK17A and CCT5. The risk scores based on these two hub genes are associated with multiple programmed cell death (PCD) pathways. Additionally, in vivo experiments using SD rats validated the expression patterns of these hub genes and found that rats in the T2DM group exhibited increased levels of MDA and lactate dehydrogenase (LDH), while superoxide dismutase (SOD) activity decreased, accompanied by increased apoptosis of islet cells. These results suggest that STK17A and CCT5 may play key roles in the pathogenesis and development of IGT and T2DM by regulating oxidative stress, programmed cell death, and key signaling pathways such as p53 and MAPK, ultimately leading to islet cell apoptosis.